{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT03983954: Phase 1 Interventional Recruiting ER+ Breast Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02137343: Phase 3 Interventional Terminated Gastric Cancer
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02098473: Phase 2 Interventional Completed Eosinophilic Esophagitis
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00435916: Phase 2 Interventional Completed Lymphoma, Large B-Cell, Diffuse
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03736447: Phase 3 Interventional Completed Peanut Allergy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00670592: Phase 1/Phase 2 Interventional Completed Non-Hodgkin's Lymphoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01110720: Phase 2/Phase 3 Interventional Completed Progressive Supranuclear Palsy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00877656: Phase 2/Phase 3 Interventional Completed T Cell Lymphoma
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00352131: Phase 1 Interventional Completed Non-colorectal Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04129775: Phase 1/Phase 2 Interventional Completed Sensorineural Hearing Loss
(2019)
Source URL:
Class:
PROTEIN